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Introduction
The granzymes, a family of structurally related serine proteases 
expressed in cytotoxic lymphocytes, cooperatively bring about 
the death of transformed and virus-infected cells after their 
  cosecretion with perforin (Trapani and Smyth, 2002). Perforin 
is critical for permitting the access of granzymes and other 
granule-bound toxins to their substrates within the target cell 
(Froelich et al., 1996; Browne et al., 1999), and as a result, all 
granzyme-dependent cell death pathways are halted in its 
 absence, leading to marked immunodefi  ciency in humans (Stepp 
et al., 1999; Voskoboinik et al., 2004) and mice (Kagi et al., 
1994). By comparison, defi  ciency of an individual granzyme is 
better tolerated by gene-targeted mice. The absence of gran-
zyme B (GrB), which cleaves target cell proteins adjacent to 
 aspartate residues, results in delayed target cell DNA fragmenta-
tion during apoptosis of most, but not all, cell types (Heusel et al., 
1994; Simon et al., 1997; Pardo et al., 2002). GrA induces a 
caspase-independent form of cell death that involves the induc-
tion of single-stranded DNA nicks after cleavage and activation 
of constituents of the SET complex (Lieberman and Fan, 2003). 
Proapoptotic function has also more recently been described 
for GrC (Johnson et al., 2003) and GrM (Kelly et al., 2004; 
Lu et al., 2006).
All of the granzymes and the closely related myeloid ser-
ine proteases, such as cathepsin G (CatG), are members of the 
chymotrypsin superfamily and, like chymotrypsin, are synthe-
sized as preproenzymes (Salvesen and Enghild, 1990; Dikov 
et al., 1994). The signal peptide is cleaved by a signal peptidase 
in the endoplasmic reticulum, before transport to the granules 
(Caputo et al., 1993; Dikov et al., 1994). The proteases are then 
stored within the granules as active enzymes after further lim-
ited proteolysis that removes a two-amino-acid activation pep-
tide at their N terminus (Jenne et al., 1988a). This enables the 
protease to assume the correct conformation for access and 
  hydrolysis of substrate (Salvesen and Enghild, 1990). A similar 
process is used in the activation of the mast cell proteases, which 
are also stored as active enzymes in the lysosomal compartment 
(Salvesen and Enghild, 1990; Dikov et al., 1994). Inhibition of 
a specifi  c dipeptidyl peptidase, CatC (dipeptidylpeptidase I) can 
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athepsin C activates serine proteases expressed in 
hematopoietic cells by cleaving an N-terminal 
  dipeptide from the proenzyme upon granule 
packaging. The lymphocytes of cathepsin C–null mice are 
therefore proposed to totally lack granzyme B activity and 
perforin-dependent cytotoxicity. Surprisingly, we show, 
using live cell microscopy and other methodologies, that 
cells targeted by allogenic CD8
+ cytotoxic T lymphocyte 
(CTL) raised in cathepsin C–null mice die through perforin-
dependent apoptosis indistinguishable from that induced 
by wild-type CTL. The cathepsin C–null CTL expressed 
  reduced but still appreciable granzyme B activity, but 
minimal granzyme A activity. Also, in contrast to mice with 
inactivation of both their granzyme A/B genes, cathepsin C 
deﬁ  ciency did not confer susceptibility to   ectromelia virus 
infection in vivo. Overall, our results indicate that although 
cathepsin C clearly generates the majority of granzyme B 
activity, some is still generated in its absence, pointing to 
alternative mechanisms for granzyme B processing and 
activation. Cathepsin C deﬁ  ciency also results in consider-
ably milder immune deﬁ  ciency than perforin or granzyme 
A/B deﬁ  ciency.
Correspondence to Joseph A. Trapani: joe.trapani@petermac.org
Abbreviations used in this paper: AV, annexin V; BLT, N
a-CBZ-L-lysine thiobenzyl 
ester; Cat, cathepsin; CTL, cytotoxic T lymphocyte; ECTV, ectromelia virus; 
NE, neutrophil elastase; NK, natural killer; PI, propidium iodide; PLS, Papillon-
Lefevre syndrome.
The online version of this article contains supplemental material.JCB • VOLUME 176 • NUMBER 4 • 2007  426
prevent this processing and activation (McGuire et al., 1993). 
Transfection of mammalian COS-7 (Caputo et al., 1993; Smyth 
et al., 1995) or yeast (Pham et al., 1998) cells with granzyme 
cDNA constructs that retained the activation dipeptide resulted 
in the expression of inactive protease. However, the activity 
could be rescued by exogenous treatment of cell lysates or puri-
fi  ed granzyme protein with CatC (Kummer et al., 1996; Pham 
et al., 1998), by coexpression of progranzyme and active CatC 
in the same cells or by deleting the dipeptide sequence before 
transfection (Caputo et al., 1993; Smyth et al., 1995).
Further evidence for a critical role of CatC in the processing 
of granzymes and myeloid cell serine proteases came from 
gene-knockout studies, in that a CatC-defi  cient mouse was gen-
erated by homologous recombination with an inactive CatC 
gene (Pham and Ley, 1999). Several studies have examined the 
effect of CatC deletion on the activity both of the granzymes 
and the structurally related mast cell and neutrophil proteases 
(Pham and Ley, 1999; Wolters et al., 2001; Adkison et al., 2002). 
Effector lymphocytes generated from these mice were reported 
to be as defi  cient as perforin-null mice in their ability to induce 
apoptosis of target cells, although only DNA fragmentation was 
assayed in these studies (Pham and Ley, 1999; Podack, 1999). 
No tryptase and only minimal ASPase activity could be detected 
in the granules isolated from CatC-null lymphocytes (Pham and 
Ley, 1999; Podack, 1999). Thus, it appeared that CatC defi  -
ciency effectively recapitulated the GrAB-null phenotype in 
  cytotoxic lymphocytes and would also result in minimal activity 
from the other granzymes.
Given the proposed generic role for CatC in granzyme 
  activation, we reasoned that cytotoxic T lymphocyte (CTL) from 
CatC
−/− mice might allow us to study the physiological role of 
perforin in a setting where all of the killer cell granzymes were 
not expressed. Also, as perforin is present in CTLs of both 
GrAB
−/− and CatC
−/− mice, comparing these CTLs would also 
allow us to determine the physiological role of the remaining 
“orphan” granzymes expressed in the GrAB
−/− mice. Surpris-
ingly, we found low but clearly measurable residual GrB ac-
tivity in the absence of CatC expression, and that effector 
lymphocytes from CatC-null mice could induce apoptosis of 
target cells by a mechanism that was indistinguishable from 
classic apoptosis. Unlike GrAB
−/− mice, which are exquisitely 
sensitive to infection with ectromelia virus (ECTV; mouse pox), 
CatC-defi  cient effector lymphocytes also mediated resistance to 
ECTV in vivo, so that infected mice were as resistant to the 
virus as wild-type C57BL/6 (B6) mice.
Results
CatC-deﬁ  cient CTLs induce target 
cell death through apoptosis
It has previously been reported that CatC
−/− gene-targeted mice 
lack GrA and -B activities and therefore have severe defects 
of granule-mediated lymphocytotoxicity (Pham and Ley, 1999; 
Podack, 1999). To explore this issue further, we generated allo-
reactive CTLs in standard, one-way (H-2
b anti–H-2
k), mixed 
lymphocyte reactions and assessed the capacity of B6.CatC
−/− 
effector cells to kill mouse MS9II (H-2
k) target cells. We had 
previously used time-lapse microscopy at 37°C to characterize 
in real time the morphological and molecular events accom-
panying the death of MS9II target cells in response to allo-
  reactive CTLs raised in B6 or B6.GrAB
−/− mice (Waterhouse 
et al., 2006). This methodology allowed us to examine changes 
in cell morphology and the appearance of classic markers of apop-
tosis in response to CTL attack. By adding soluble annexin V 
(AV) and propidium iodide (PI) to the medium, we were able 
to track phosphatidylserine exteriorization (a relatively early 
marker of apoptosis) and loss of plasma membrane integrity 
(a late marker), respectively, as a function of time. Both B6 and 
B6.GrAB
−/− CTLs induced classic apoptotic changes, such as 
cell shrinkage, marked membrane blebbing, and nuclear col-
lapse with indistinguishable kinetics (Waterhouse et al., 2006). 
However, a major point of difference was that although B6 
CTLs induced early and marked target cell AV binding, cells 
killed by GrAB
−/− CTLs did not stain with AV until very late, 
simultaneously with loss of plasma membrane integrity (Water-
house et al., 2006).
Given that, like GrAB
−/− CTLs, CatC
−/− CTLs had also 
been found to lack GrA or -B activity (Pham and Ley, 1999), we 
were surprised to fi  nd that MS9II cells exposed to CatC
−/− 
CTLs underwent morphological and molecular events of apop-
tosis that were indistinguishable from B6 CTLs, both in their 
amplitude and timing. B6 or B6.CatC
−/− effector cells were 
added to equal numbers of the much larger and adherent MS9II 
target cells. The time course of death in a single representative 
target cell is shown (Fig. 1 A). In this cell, rounding occurred 
at  1 h 10 min, followed by AV binding at 1 h 45 min and 
PI uptake at 2 h 25 min. Fig. 1 B and Video 1, available at 
http://www.jcb.org/cgi/content/full/jcb.200609077/DC1, illustrate 
the sequence of events for the same cell, including conjugate 
formation with the CTL (t = 0.5 h), cell rounding and plasma 
membrane blebbing (t = 1.5 h), AV binding (t = 2.0 h), and PI 
uptake (t = 2.5 h). By making similar observations on a large 
number of dying target cells, it was possible to compare both 
the morphology and kinetics of death induced by CatC-defi  cient 
and -suffi  cient CTLs (Fig. 1 C) with those raised in GrAB
−/− 
mice (Waterhouse et al., 2006). Taking the time of rounding 
as a common reference point (i.e., t = 0), no difference was 
  observed in the kinetics of cell death (morphological changes; 
AV or PI staining) over populations of cells killed by B6 CTLs 
(n = 20) or B6.CatC
−/− CTLs (n = 25). The killing observed in 
these assays was mediated though the granule pathway in that 
CTLs raised simultaneously in perforin-defi   cient mice were 
unable to kill the same target cells, as demonstrated both by 
time-lapse microscopy (not depicted) or 4-h 
51Cr release assays, 
whereas target cells released 
51Cr in response to both wild-type 
and CatC
−/− CTLs (Fig. 1 D). Cell death by perforin-induced 
lysis was excluded, as the kinetics and morphology of this form 
of cell death are quite easily distinguished from apoptosis 
  (Waterhouse et al., 2006). We also demonstrated by Western blot 
that the CatC
−/− mice had not up-regulated their level of perforin 
or GrB protein expression compared with B6 CTLs (Fig. 1, 
E and F). In total, these observations strongly suggested that the 
CatC-defi  cient effector cells induce apoptotic death similar to 
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by CTLs raised from mice with structural disruption of both 
their GrA and -B genes.
To exclude the possibility that the aforementioned fi  nd-
ings were peculiar to MS9II target cells or the specifi  c strain 
combination used to raise allo-reactive CTLs, we exposed 
51Cr-
labeled P815 mouse mastocytoma tumor cells (H-2
d) to B6 
CTLs stimulated with irradiated BALB/c splenocytes. Unlike 
MS9II cells (which have a relatively long doubling time), the 
DNA of rapidly dividing P815 cells labels well with 
125I-UdR, 
so that cells doubly labeled with 
51Cr and 
125I can be used to 
  simultaneously evaluate plasma membrane permeability and 
DNA fragmentation. Both day 7 primary (Fig. 2 A) and day 3 
secondary (Fig. 2 B) CTLs of B6 mice produced strong 
51Cr and 
125I-DNA release that was only slightly diminished when CTLs 
from B6.CatC
−/− mice were used. This killing was once again 
mediated through the granule pathway, as doubly stimulated 
perforin-defi  cient CTLs induced neither 
51Cr or 
125I release, 
whereas the cell death induced by day 7 primary B6 CTLs was 
totally inhibited when free calcium in the reaction medium was 
complexed with EGTA (Fig. 2 and Fig. S1, available at http://
www.jcb.org/cgi/content/full/jcb.200609077/DC1).
Additional effector cell types were examined to determine 
whether the cytotoxic activity observed in allo-stimulated 
CatC-null CTLs was also seen in other effector lymphocytes. 
Unfractionated splenic natural killer (NK) cells or purifi  ed 
DX5
+CD3
− cells activated with IL-2 each induced 
51Cr release 
from Yac-1 target cells in a perforin-dependent manner, but this did 
not vary whether CatC was expressed or not (unpublished data).
Granule serine protease activity 
in CatC
−/− lymphocytes
Although perforin and granzymes synergistically bring about 
target cell apoptosis, it is well recognized that purifi  ed perforin 
is unable to induce DNA fragmentation, but only causes cell 
lysis (Duke et al., 1989). When delivered by a CTL or NK cell, 
GrA and -B activate separate signaling pathways, resulting in 
DNA nicking or oligonucleosomal fragmentation, respectively, 
in a perforin-dependent manner (Shi et al., 1992; Beresford 
Figure 1. CatC
−/− CD8
+ CTLs induce apoptosis in target cells. (A) Kinetics of apoptotic events in a representative MS9II target cell after exposure to BL/6.
CatC
−/− effector lymphocytes (>90% CD8
+) generated from day 3 secondary-stimulated mixed lymphocyte reaction (H-2
b anti H-2
k). Phosphatidylserine 
exposure was measured by the ﬂ  uorescence of AV binding, and loss of membrane integrity was measured by PI uptake, relative to maximum ﬂ  uorescence. 
In these experiments, t = 0 was taken as the time at which target cell rounding occurred. There was no difference in the cumulative number of target cells 
becoming rounded, either in the presence or absence of CatC expression. Images were recorded every 5 min. (B) The morphology of the cell in A is shown 
in the series of photographs. T = 0 h shows the untreated target cell, t = 0.5 h shows CTL–target cell conjugation (CTL is enclosed by a white line and 
marked with an asterisk), and t = 1.5 h shows the round/blebbing target cell. AV binding is clearly evident at t = 2.0 h, and PI uptake is evident by t = 
2.5 h. See Video 1 (available at http://www.jcb.org/cgi/content/full/jcb.200609077/DC1). (C) The duration from rounding to AV binding and AV 
binding to PI uptake was calculated for individual target cells incubated with either B6 or B6.CatC
−/− CTL. Mean ± SEM (n = 20 for B6 treated cells, and 
n = 25 for B6.CatC
−/− treated cells). (D) BL/6, BL/6.CatC
−/−, and B6.pfp
−/− effector lymphocytes (H-2
b anti H-2
k; >90% CD8
+) were incubated with 
51Cr -labeled MS9II target cells in a 4-h assay at the effector/target ratios indicated. In each case, the data points show the mean of independent experi-
ments (each of which was performed in triplicate) ± SEM. The number of independent experiments performed for each effector type is indicated in the ﬁ  gure. 
(E) Western blot analysis showing the presence of perforin using the rat monoclonal antibody PI-8 in the lysates of activated T cells from the various mouse 
strains indicated. Two pools of two mice (shown in separate lanes) were used for each strain. Blot was reprobed with an anti-tubulin antibody. 
(F) Western blot analysis showing the presence of GrB in the lysates of activated T cells from the various mouse strains indicated. Blot was reprobed with 
an anti-actin antibody.JCB • VOLUME 176 • NUMBER 4 • 2007  428
et al., 1999). Rapid fragmentation of target cell DNA, a hallmark 
of apoptosis induced through the granule-exocytosis mecha-
nism, in most cell types is largely due to the action of active 
GrB (Heusel et al., 1994; Trapani et al., 1998a,b; Pardo et al., 
2002). Consistent with these previous fi  ndings, we found that 
DNA fragmentation was abolished in P815 target cells exposed 
to GrAB
−/− CTLs, whereas appreciable 
51Cr release was still 
observed, as previously reported (Simon et al., 1997; Waterhouse 
et al., 2006; Fig. 2). In contrast, CatC-null CTLs were effi  ciently 
able to induce DNA fragmentation of P815 cells (Fig. 2). 
Although an earlier study failed to fi  nd evidence of GrA or -B 
activity in the lymphocytes of CatC-null mice (Pham and Ley, 
1999), the similar kinetics of the apoptotic events detailed in 
CatC-suffi  cient and -defi  cient CTLs (Fig. 1) suggested that some 
serine protease (i.e., granzyme) activities might be generated in 
allo-stimulated, CatC-defi  cient CTLs. In addition to activating 
granzymes, CatC has been reported to be critical for activation 
of serine proteases in monocytes/neutrophils (Adkison et al., 
2002) and mast cells (Wolters et al., 2001). To show that inacti-
vation of the CatC gene abolished the activity of certain specifi  c 
serine proteases in myeloid cells and to reconfi  rm the myeloid 
cell phenotype of the CatC
−/− mice, CatG and neutrophil elas-
tase (NE) were assayed in bone marrow neutrophils purifi  ed 
from mice administered granulocyte colony-stimulating factor, 
as described previously (Adkison et al., 2002). The hydrolysis 
of NE- and CatG-specifi  c substrates was measured in a chromo-
genic assay using lysates of bone marrow cells from wild-type 
B6 and B6.CatC
−/− mice. As expected (Adkison et al., 2002), 
the activity of both enzymes was virtually abolished (reduced 
by >98%) in the absence of CatC expression (Fig. S2, available 
at http://www.jcb.org/cgi/content/full/jcb.200609077/DC1).
To test the possibility that the CTLs of CatC
−/− mice were 
still capable of some residual granzyme activation, lysates pre-
pared from allo-stimulated primary and secondary CD8
+ CTLs 
(>90% pure) were assayed for their capacity to hydrolyze the 
GrB-specifi  c substrate Ala-Ala-Asp-S-benzyl (cleavage after 
asp or ASPase activity), N
a-CBZ-L-lysine thiobenzyl ester 
(BLT; to measure trypsin-like GrA [tryptase] activity) and Phe-
Leu-Phe-S-Benzyl (chymotrypsin-like or chymase activity; 
Fig. 3). It became clear that although GrB activity was mark-
edly reduced, it was not abolished in the CatC
−/− cells. In 
  kinetic assays, ASPase activity was reduced but still clearly 
  detectable in the lysate of day 7 primary (Fig. 3 A) or day 3 sec-
ondary (Fig. 3 D) allo-stimulated CatC-null CTLs, albeit with 
some delay compared with CatC-suffi  cient cells. Not surpris-
ingly, there was greater ASPase activity in twice-stimulated 
CD8
+ cells; however, maximum substrate hydrolysis was 
reached by 10 min in both cases. The ASPase substrate, Ala-
Ala-Asp-SBzl is cleaved only by GrB: it is not cleaved by cas-
pases, proapoptotic cysteine proteases that also cleave after 
specifi  c aspartate residues. We also performed an additional 
  important control to examine the reliance of substrate turnover on 
the presence of bona fi  de granzyme activity: we demonstrated 
that no ASPase activity whatsoever was present in the CTLs of 
GrAB-null cells, in which the GrB gene is structurally disrupted 
(Fig. 3, A, D, and E). This observation ruled out any incidental 
cleavage by proteases other than GrB as a cause of substrate 
hydrolysis in the CatC-null cells. The presence of ASPase 
 activity in the CatC-null lysate was again confi  rmed when lysates 
containing equal amounts of protein from one of the experi-
ments shown in Fig. 3 D were progressively diluted and the 
  assay was performed for 15 min. At each lysate dilution, the 
level of ASPase activity was about one third of that seen in B6 
lysates (Fig. 3 E). As expected, normal activity was noted in the 
B6.pfp
−/− lysates. As the substrate used in these assays is spe-
cifi  c for GrB, these results indicate that a proportion of the GrB 
precursor expressed in the CatC-null effectors had been acti-
vated. In contrast to ASPase activity, no measurable tryptase 
(GrA) activity was detected in either the CatC-null or GrAB
−/− 
lysates, indicating that GrA (and the second tryptase, GrK) 
were not activated in the CatC
−/− CTLs (Fig. 3, B and F). As 
expected, the turnover of the chymase substrate in the same lysates 
was not reduced in any of the lysates tested (Fig. 3, C and G). 
This indicated that CatC is not essential for the processing of at 
least some of the granzymes with chymase activity, presumably 
GrC–F (Trapani, 1998).
CatC-null mice are relatively resistant 
to ECTV
It was previously demonstrated that normally resistant B6 mice 
lacking both GrA and -B or perforin are incapable of controlling 
Figure 2. CatC
−/− CTLs induce both plasma membrane damage and DNA 
fragmentation in target cells. 
51Cr release and 
125I-DNA release from target 
cells were used as measures of membrane damage and DNA fragmenta-
tion, respectively. 
51Cr- and 
125I-UdR–labeled P815 mastocytoma cells were 
coincubated for 4 h with day 7 primary stimulated (A) or day 3 secondarily 
stimulated (B) effector cells (H-2
b anti-H-2
d) from BL/6 and BL/6.CatC
−/− 
mice. BL/6.GrAB
−/− and BL/6.pfp
−/− effectors were also examined in B. 
The data points show the mean of independent experiments (each of which 
was performed in triplicate) ± SEM. The number of independent experi-
ments performed for each effector type is indicated in the ﬁ  gure. E:T, effector/
target ratio.GRB ACTIVATION AND CTL ACTIVITY IN CATC
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primary infection by the natural mouse pathogen ECTV, an 
  orthopoxvirus (Mullbacher et al., 1999a,b). These mice are 
  unable to control ECTV replication, and viral load in their 
spleen is several orders of magnitude higher than B6 mice 
(Mullbacher, 2003). We therefore estimated viral titers in the 
spleens and livers of CatC-null and -suffi  cient B6 mice after 
ECTV   infection into the footpad (Fig. 4). Viral titers in spleen 
and liver were estimated at 2, 4, 6, and 8 d after infection and 
showed no measurable difference at any time point. In contrast, 
defi  ciency of both GrA and -B has been shown to increase viral 
titer in the liver and spleen  10,000-fold by days 6 and 8, 
  compared with granzyme-expressing mice (Mullbacher et al., 
1999b). In addition, we found that the CatC-null mice had only 
a slightly higher mortality than wild-type mice, but far lower 
than that seen in perforin or GrAB-defi  cient mice (unpublished 
data). Overall, our data indicated that the phenotype of CatC-
null mice with respect to ECTV infection in vivo is distinct 
from that of perforin or GrAB-defi  cient mice on the same ge-
netic background; namely, perforin- and GrAB gene-disrupted 
mice are far more susceptible.
Discussion
The lymphocyte and myeloid cell serine proteases are unusual 
amongst proteolytic enzymes in that they are stored in secretory 
lysosomes as active enzymes (Salvesen and Enghild, 1990). 
  Activation is a two-step process and involves removal of the 
leader sequence followed by cleavage of two fi  nal residues at 
the N terminus at the time of granule packaging (Masson and 
Tschopp, 1987; Bleackley et al., 1988; Caputo et al., 1993). 
Studies using protease inhibitors or in which purifi  ed CatC 
Figure 3.  Serine protease activities in CatC-null and -expressing day 7 
primary and day 3 secondary allo-stimulated CD8
+ lymphocytes. Approxi-
mately 20 μg of whole cell lysate protein prepared from puriﬁ  ed CD8
+ 
T cells from day 7 primary (A–C) or day 3 secondary (D–G) CTLs were as-
sayed for various granzyme activities as a function of time. In A, D, and E, 
ASPase activity was measured by hydrolysis of the peptide thioester sub-
strate Boc-Ala-Ala-Asp-S-Bzl, which is speciﬁ  cally cleaved by Gr B. In E, 
single lysates from one of the experiments shown in D were progressively 
diluted and tested in triplicate for 15 min. (B and F) Tryptase activity was 
measured by cleavage of BLT; (C and G) chymotrypsin-like (chymase) activity 
was measured by cleavage of Suc-Phe-Leu-Phe-SBzl. The data points show 
the mean of independent experiments (each of which was performed in 
triplicate) ± SEM. The number of independent experiments performed for 
each effector type is indicated in the ﬁ  gure.
Figure 4.  ECTV titers in the spleens and livers of CatC-expressing and -null 
mice. Mice were infected in the hind footpads with ECTV as described in 
Materials and methods. Groups of three mice were killed on days 2, 4, 6, 
and 8 after infection, and their organs were assayed for virus titers by 
plaque assay on BSC-1 cell monolayers. In each panel, the horizontal line 
indicates the detection limit of the assay.JCB • VOLUME 176 • NUMBER 4 • 2007  430
was added to recombinant granzymes (Caputo et al., 1993; 
 McGuire  et  al., 1993; Smyth et al., 1995; Kummer et al., 
1996; Pham et al., 1998) or, fi  nally, with CatC-knockout mice 
(Pham and Ley, 1999) indicated that CatC is the principal protease 
that removes the activation dipeptide. Our current study clearly 
confi  rms that CatC is responsible for virtually all of the GrA 
and most of the GrB activity in CTLs. However, our results also 
clearly indicate that not all of the GrB activity is eliminated in 
CatC
−/− mice and that the extent of the immune defect of CatC-
null mice may have been overestimated in the past.
Surprisingly, we have found that although CatC seems to 
be critical for activating GrA, it is not essential for GrB activity. 
As a result, CatC-defi  cient mice retain substantial CTL cyto-
toxicity, inducing apoptosis in vivo and in vitro. The reduced 
GrB activity of CatC
−/− CTLs was still suffi  cient to induce 
DNA fragmentation in target cells that was comparable to that 
induced by wild-type effector cells. This indicated that the 
quantity of GrB released by wild-type CTLs is well in excess of 
the amount required to trigger DNA fragmentation in P815 
cells. Much of the DNA fragmentation induced by GrB is nor-
mally reliant on caspase activation (Sarin et al., 1998; Trapani 
et al., 1998a), so the suffi  ciency of CatC
−/− CTLs in inducing 
DNA fragmentation indicates that the quantity of GrB deliv-
ered by these cells is adequate to effectively initiate caspase 
processing. Similarly, live-cell imaging demonstrated that target 
cells exposed to CatC
−/− CTLs died by classic apoptosis: both 
the morphology and the acquisition of apoptotic markers (phosphat-
idylserine exposure, PI uptake) as a function of time were in-
distinguishable between cells incubated with CatC-defi  cient 
or -suffi  cient killer cells. In vivo, CatC-null mice were far less 
susceptible to both GrAB
−/− and pfp
−/− mice to ECTV, and viral 
titers generated in their livers and spleens were comparable to 
those in wild-type B6 mice. Indeed, the kinetics of virus repli-
cation in CatC
−/− mice matched that seen with GrA
−/− mice 
(Mullbacher et al., 1996,b), which is consistent with our fi  nd-
ings that the CatC
−/− lacked GrA expression but retained mea-
surable GrB activity. Overall, the current study makes it clear 
that CatC-null mice are considerably less immunologically com-
promised than either GrA/B-cluster or perforin-defi  cient mice 
and that alternative mechanisms exist for GrB activation in the 
absence of CatC.
A lack of neutrophil serine protease activity has been 
 observed in CatC
−/− mice (Adkison et al., 2002), as was confi  rmed 
in our study. A role for these proteases in defense against bacte-
rial and fungal pathogens has been suggested (Belaaouaj et al., 
1998; Tkalcevic et al., 2000), but the only study that addressed 
this issue, surprisingly, showed that the absence of CatC con-
tributed to increased survival from sepsis (Mallen-St Clair et al., 
2004). A defi  ciency of cell-mediated immunity is not a promi-
nent feature of CatC defi  ciency in humans. Most CatC-defi  cient 
patients present with Papillon-Lefevre syndrome (PLS), a rare 
autosomal recessive disorder (Gorlin et al., 1964; Hart et al., 
1999) marked by severe, early onset periodontal disease, with 
subsequent premature loss of both primary and secondary denti-
tion, and palmoplantar hyperkeratosis (Nuckolls and Slavkin, 
1999; Toomes et al., 1999). Although the critical CatC sub-
strates responsible for PLS have not been defi  ned, it has been 
suggested that CatC may play a role in maintaining the structure 
and integrity of the epidermis surrounding the teeth (Nuckolls 
and Slavkin, 1999; Lundgren et al., 2005). An increased suscep-
tibility to bacterial infections both in the mouth and within 
  organs such as the liver has been reported and may refl  ect defects 
in neutrophil activity, manifested as an absence of CatG, NE, 
and protease 3 activity (de Haar et al., 2004; Pham et al., 2004; 
Lundgren et al., 2005). Recent reports have produced somewhat 
confl  icting results with regard to lymphocyte function in PLS 
patients. Three of the seven patients described in the aforemen-
tioned studies also had a slight reduction in GrA protein levels, 
but considerable GrA and -B activities were detected (Pham 
et al., 2004), and IL-2–activated T cells generated from these 
patients were able to effi  ciently kill K562 target cells. However, 
naive NK cells isolated from a further 20 PLS patients (repre-
senting seven families) displayed an  50% reduction in activity 
against K562, compared with a pool of normal healthy controls 
(Lundgren et al., 2005). The profi  le of effector molecules 
  expressed by these two cell types is distinct, perhaps accounting 
for the apparently discordant results (Sedelies et al., 2004). In 
particular, resting NK cells have very low levels of GrB but a 
very high constitutive level of GrH, whereas GrB expression in-
creases markedly with IL-2 stimulation (Sedelies et al., 2004). 
In another study, it was shown that the NK cells of a PLS patient 
exhibited GrB activity after stimulation with IL-2 (Meade et al., 
2006). We have found similar results in CatC-null NK cells 
 (unpublished  data).
CatC, an amino-dipeptidase, belongs to a family of lyso-
somal papain-like cysteine proteases (Rao et al., 1997). Unlike 
related proteases, which function as monomeric endopepti-
dases, CatC is an oligomeric exopeptidase with a general pre-
ference for acidic N-terminal sequences (see below) until it 
encounters a “stop sequence,” usually a charged residue, such as 
arginine, lysine, or proline (Tran et al., 2002). However, CatC is 
also well recognized for its ability to cleave the dipeptide at 
the N terminus of serine proteases found in lymphocytes and 
neutrophils. Exposure of the invariant N-terminal isoleucine in 
all granzymes allows it to form an ion pair with the aspartate 
within the catalytic pocket, which leads to the formation of a 
functional catalytic center (Salvesen and Enghild, 1990). It is 
unclear whether further trimming is prevented, as the isoleucine 
is seen as a stop sequence, or whether the ion pair formation is 
instantaneous, which makes the N terminus unavailable for fur-
ther processing. In the absence of CatC, other less specifi  c 
  lysosomal enzymes could potentially remove the activation 
  dipeptide. However, this degree of redundancy is limited, as we 
showed that GrB activity remains markedly compromised, 
whereas GrA activity remains almost completely absent. Inter-
estingly, an analogous study by Wolters et al. (2001) showed 
that tryptases but not chymases are still activated in CatC
−/− 
mast cells. Although Pham and Ley (1999) were unable to fi  nd 
evidence for dipeptide-deleted GrA and -B, they did, surpris-
ingly, fi  nd that 50% of the GrC they were able to purify from 
CatC-defi  cient CTLs had had its activation dipeptide removed, 
and they suggested that an alternative protease, DPPIV, might 
be responsible. This seems unlikely to us, as substrate analysis 
has suggested that DPPIV has a strict preference for proline in GRB ACTIVATION AND CTL ACTIVITY IN CATC
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the P1 position, although alanine was tolerated in two identifi  ed 
substrates (Leiting et al., 2003). Comparison of the dipeptide 
sequence in serine proteases found that all of the granzymes, 
with the exception of GrA, have an acidic residue (Glu) in the 
P1 position (Lobe et al., 1986; Jenne et al., 1988a,b; Jenne et al., 
1989), as do the mast cell chymases (McGuire et al., 1993; 
Dikov et al., 1994), carboxypeptidase A (Reynolds et al., 1989), 
and NE (Sturrock et al., 1998). In contrast, GrA has arginine 
(Hershberger et al., 1992), CatG has lysine (Heusel et al., 1993), 
and the mast cell tryptases have glycine (Dikov et al., 1994). 
Therefore, in terms of the specifi  city of an alternative dipepti-
dase acting in the absence of CatC, there is not a consistent 
preference for a specifi  c residue in the P1 position. We are cur-
rently attempting to identify the proteases responsible for par-
tially compensating for CatC’s absence, using biochemical and 
genetic approaches.
Materials and methods
Mice
Inbred B6 (H-2
b), BALB/c (H-2
d), and C3H/J (H-2
k) mice were purchased 
from the Walter and Eliza Hall Institute of Medical Research. GrA and GrB 
cluster–deﬁ  cient (GrAB
−/−) mice (Simon et al., 1997) were obtained from 
M. Simon (Max-Planck-Institut für Immunbiologie, Freiburg, Germany) and 
were maintained at the Peter MacCallum Cancer Centre. Mice were geno-
typed using the PCR screening protocols previously described (Simon 
et al., 1997). Originally, the GrA
−/− mice (Ebnet et al., 1995) were derived 
on the B6 background and the GrB cluster–deﬁ  cient mice (Heusel et al., 
1994) on the129 background. After appropriate matings and selection of 
GrAB
−/− progeny, the mice were backcrossed for eight generations to B6. 
The CatC (dipeptidyl peptidase 1) knockout (B6.CatC
−/−) mice (Pham and 
Ley, 1999) were provided by C. Pham (Washington University School of 
Medicine, St. Louis, MO) and maintained at the Peter MacCallum Cancer 
Centre. The B6.CatC
−/− mice had previously been backcrossed to B6 for 
11 generations. We used a PCR screening protocol provided by C. Pham 
to conﬁ  rm disruption of the CatC gene and acquisition of the Lac Z cassette 
in knockout animals (Pham and Ley, 1999). We also recapitulated the 
  myeloid phenotype of the mice by conﬁ  rming the absence of active CatG 
and NE from neutrophils (Fig. S2; see the following paragraph). Mice 
5–10 wk of age were used in all experiments, and the studies conformed 
to Peter MacCallum Cancer Centre and the John Curtin School of Medical 
Research animal experimental ethics committee guidelines.
Enzyme activity assays
Whole cell lysates of CTLs generated in mixed lymphocyte cultures were 
normalized for protein content and analyzed for granule serine protease 
activity by the hydrolysis of synthetic peptide thiobenzylester substrates: for 
ASPase activity, Boc-Ala-Ala-Asp-S-Bzl (a gift from J. Powers, Georgia Insti-
tute of Technology, Atlanta, GA); for tryptase activity, BLT (Sigma-Aldrich); 
and for chymotrypsin-like (chymase) activity, Suc-Phe-Leu-Phe-SBzl (Enzyme 
Systems Products), as described previously (Edwards et al., 1999; Davis 
et al., 2003). The failure of CatC
−/− mice to activate the bone marrow–
  derived serine proteases NE and CatG was conﬁ  rmed by the lack of cleav-
age of speciﬁ  c peptide paranitroanilide substrates in chromogenic assays 
as previously described (MacIvor et al., 1999; Adkison et al., 2002). 
  Absorbance readings (at 405 nM) were taken at 15 min. The data points 
shown represent the means ± SEM.
Cell culture and reagents
P815 (mouse mastocytoma; H-2
d) and MS9II (mouse ﬁ  broblast; H-2
k) cells 
were maintained in DME (JRH Bioscience) supplemented with 10% (vol/
vol) FCS (JRH Bioscience), 2 mM glutamine (JRH Bioscience), 100 U/ml 
penicillin, 100 μg/ml streptomycin (Invitrogen), and 1 mM sodium pyru-
vate (Invitrogen). Primary mouse CTLs were maintained in supplemented 
RPMI (Invitrogen) also containing 100 μM nonessential amino acids and 
0.1 mM 2-mercapto-ethanol. Western blot analysis (Sutton et al., 2000) 
was used to conﬁ   rm perforin expression using the rat PI-8 antibody 
(Kamiya Biomedical; Kawasaki et al., 1990) and GrB expression using the 
rat anti-GrB antibody (eBioscience).
Generation of cytotoxic lymphocytes
Allogenic CTLs capable of recognizing H-2
d expressed on P815 cells or 
H-2
k on MS9II cells were generated in one way in vitro mixed lymphocyte 
reactions. Splenocytes isolated from B6 and the gene-targeted mouse strains 
listed above were cultured for 7 d in RPMI medium with lethally irradiated 
BALB/c (H-2
d) or C3H/J (H-2
k) splenocytes. The stimulator/responder cell 
ratio was 1:1, and responder cells were seeded at 2 e6 cells per milliliter 
of culture medium in 24-well plates. In some experiments, the cells were re-
stimulated in a similar fashion for a further 3 d. Cell death induced by CTL 
populations was assessed by 
51Cr and 
125I-DNA release, as described pre-
viously (Sutton et al., 1997).
Time-lapse confocal microscopy
Time-lapse confocal microscopy was performed essentially as previously 
described (Waterhouse et al., 2006). In brief, MS9II cells were plated and 
allowed to adhere to 96-well culture plates and incubated overnight 
at 37°C in a humidiﬁ  ed CO2 incubator. The plates were transferred to a 
temperature-controlled stage (Prior Proscan) maintained at 37°C on a micro-
scope (IX-81; Olympus). PI (Sigma-Aldrich) was added to the cultures, in 
tissue culture medium (DME) at 50 ng/ml and AV-FLUOS (Roche) at 2 μg/ml. 
Cells were exposed to an equal number of activated CD8
+ CTLs and 
viewed for the times indicated. Images were captured at speciﬁ  ed intervals 
using a charge-coupled device camera (ORCA-ER; Hamamatsu) controlled 
by MetaMorph software (Universal Imaging Corp.). The images were 
viewed with an LCPlanFl objective lens at 20× (NA 0.4). As the ﬂ  uores-
cence intensities of AV-FLUOS and PI varied, we plotted the ﬂ  uorescence 
reading for each frame relative to the maximum for that ﬂ  uorochrome over 
the entire time course (using MetaMorph and Excel [Microsoft]), after sub-
traction of background ﬂ  uorescence at each time point. For each ﬂ  uoro-
phore, the maximum ﬂ  uorescence plotted was therefore deﬁ  ned as 1.0, 
and baseline ﬂ  uorescence was 0.
Infection with ECTV in vivo
The kinetics of ECTV replication were estimated as previously described 
(Mullbacher et al., 1996). Mice were infected with 10
3 pfu ECTV (Moscow 
strain) into the footpad. Three mice were killed on days 2, 4, 6, and 8 after 
infection, and liver, spleen, and blood were harvested. The viral titers 
in spleen and liver were determined as described previously (Mullbacher 
et al., 1996).
Online supplemental material
Fig. S1 demonstrates a chromium release assay showing that apoptosis 
  induced by CD8
+ CTLs is granule mediated. Fig. S2 demonstrates a chromo-
genic substrate cleavage assay showing CatG and NE activities in CatC-null 
and -expressing neutrophils. Video 1 is a time-lapse video of CatC-null CTL-
induced death of an MS9II target cell. Online supplemental material is avail-
able at http://www.jcb.org/cgi/content/full/jcb.200609077/DC1.
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